ZIMMER BIOMET HOLDINGS, INC. 8-K

What Happened
Zimmer Biomet Holdings, Inc. (ZBH) filed a Form 8-K on May 27, 2026 reporting the results of its annual meeting of shareholders held May 22, 2026. Shareholders elected ten directors to one-year terms, ratified PricewaterhouseCoopers LLP as the independent registered public accounting firm for 2026, approved the advisory "say-on-pay" vote for named executive officer compensation, and rejected a shareholder proposal calling for an independent board chairman.

Key Details

• Ten directors were elected to one-year terms ending at the 2027 annual meeting; vote totals varied by nominee (examples: Louis A. Shapiro — 167,514,405 For; Devdatt Kurdikar — 160,889,975 For). Broker non-votes totaled 12,009,707 for director elections.
• Proposal 2 (ratify PwC as auditor): 172,738,361 For, 7,887,786 Against, 110,176 Abstain.
• Proposal 3 (advisory approval of executive compensation): 160,066,066 For, 8,386,847 Against, 273,703 Abstain; 12,009,707 broker non-votes.
• Proposal 4 (shareholder proposal to require an independent board chair) was rejected: 31,288,886 For, 137,043,058 Against, 394,672 Abstain; 12,009,707 broker non-votes.

Why It Matters
These results confirm the company’s board and governance structure for the coming year and preserve continuity in external audit oversight with PwC appointed for 2026. The advisory approval of executive compensation (say-on-pay) reflects majority shareholder support for the disclosed pay practices, while the decisive rejection of the independent-chair proposal indicates shareholders did not mandate a change to the company’s current board leadership structure. Investors should view this filing as a formal record of governance and shareholder sentiment rather than a disclosure of financial performance.